Ambulatory haematological cancer service

Sheffield Teaching Hospitals NHS Foundation Trust

  • Project led by Sheffield Teaching Hospitals NHS Foundation Trust in partnership with Sheffield School of Health and Related Research.
  • Focused on haemotological cancer care.
  • Aimed to develop ambulatory care treatment pathways for blood cancer patients to reduce length of inpatient stay, minimise delays in treatment delivery and enhance the patient experience.
  • Used Clinical Microsystems as a service improvement tool to design new treatment pathways and to engage staff and patients in the process.

The Sheffield Teaching Hospitals team developed ambulatory care treatment pathways for blood cancer patients. Ambulatory care involves delivering care on a day case basis or at home. The aims of the project were to:

  • reduce length of inpatient stay
  • minimise delays in treatment delivery
  • increase bed capacity
  • enhance the patient experience.

The team used Clinical Microsystems as a service improvement tool to design the treatment pathways and to engage staff and patients in the process. They developed a range of resources and services including:

  • new protocols and guidelines
  • a patient and carer education programme
  • patient information booklets
  • a patient alert card
  • ambulatory care flats and hotel services
  • extended opening hours for the day ward including on weekends.

Who was involved

The Clinical Microsystems team involved doctors, nurses, patients, managers and hotel services, along with a health economist and a pharmacist. The economic impact of the project was led by Sheffield School of Health and Related Research.

Outcomes

The team treated 13 blood cancer patients using ambulatory care pathways between April 2011 and February 2012. All patients treated gave positive feedback. 

Ambulatory care significantly reduced the median inpatient length of stay for:

  • acute myeloid leukaemia patients receiving consolidation chemotherapy - 7 days compared to 25 days for standard inpatient treatment
  • lymphoma patients receiving high dose therapy with stem cell support - 9.5 days compared to 21 days.

Computer simulation modelling predicted that ambulatory care could enable the unit to perform an additional 6-10 bone marrow transplants each year and reduce yearly treatment costs by 7-11%.

Further reading

Learning report

Shine: Improving the value of local healthcare services

Successes and lessons from the first two rounds of the Health Foundation’s Shine programme: annual awards to test small-scale...

You might also like...

Blog

A combined effort for autism: lessons from the community for the health system

Research shows 88% of autistic people do not think their needs are understood by health professionals. Emily Niner and Oliver...

Press release

Health and care services face a perfect storm of pressures in the coming months

Health Foundation response to NHS England monthly performance stats for September.

Blog

Collaboration is key to achieving better models of care

What effect can collaboration between patients, families and clinicians have on health care systems and practices? Maddie Jul...

Kjell-bubble-diagramArtboard 101

Work with us

We look for talented and passionate individuals as everyone at the Health Foundation has an important role to play.

View current vacancies
Artboard 101 copy 2

The Q Community

Q is an initiative connecting people with improvement expertise across the UK.

Find out more